Science policy news weekly roundup: May 22, 2015

The roundup is formatted with the title of the story, followed by the news source in parentheses and a brief summary. If you find a particularly interesting article, please send it to smartin@asbmb.org for inclusion in next week’s roundup.

Why the world needs more scientists (vox) – NIH Director Francis Collins explains the need for “more young creative minds” to drive the scientific research enterprise forward.

Young medical researchers face staggering odds (The Hill) – Congressional blog highlights the effect of restricted NIH funding on emerging medical researchers.

On the Hill

Ellmers Leads Legislation to Support Young, Emerging Scientists (ellmers.house.gov) – Congresswoman Renee Ellmers, from the 2nd district of North Carolina, introduced H.R. 2440 to amend the Public Health Service Act. This bill would enhance the loan repayment programs of the National Institute of Health (NIH).

Durbin, Graham Launch Senate NIH Caucus (durbin.senate.gov) – Recent announcement of bi-partisan Senate NIH Caucus led by Senators Durbin (D-IL) and Graham (R-SC) seeks to maintain United States status as global leader in biomedical research by investing in research.

With America COMPETES, Science Suffers (ASBMB Policy Blotter)

21st Century Cures Act

Medical cures bill unanimously passes House panel (The Hill) – House Energy and Commerce Committee unanimously passed 21st Century Cures act on Thursday 05/21/2015.

House committee approves bill on speeding medical innovation (Science Insider)

21st Century Cures Act passes committee (ASBMB Policy Blotter)

Baltimore Sun: Harris plays central role in NIH funding bill (Baltimore Sun via Bloomberg Government)- Conservative Rep. Andy Harris, anesthesiologist trained at Johns Hopkins, worked to incorporate language into 21st Century Cures Act that would secure funding for early stage investigators.

Rush Introduces Amendment to Improve Minority Inclusion in Clinical Trials (rush.house.gov) – Rep. Bobby Rush introduced two adopted provisions in the 21st Century Cure Act which seek to promote inclusion of minorities in biomedical research and clinical trials.

Leave a Reply

Your email address will not be published. Required fields are marked *